Pulmonx Corp(LUNG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LUNG Pulmonx Corp

Trading 08-06 13:31:25 EDT

2.16

+0.18

+9.09%

High2.21	Low1.93	Vol506.68K
Open1.94	D1 Closing1.98	Amplitude14.39%
Mkt Cap92.77M	Tradable Cap79.94M	Total Shares42.95M
T/O1.07M	T/O Rate1.37%	Tradable Shares37.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LUNG","market":"US","secType":"STK","nameCN":"Pulmonx Corp","latestPrice":2.16,"timestamp":1786037475660,"preClose":1.98,"halted":0,"volume":506677,"delay":0,"changeRate":0.090909090909091,"floatShares":37010998,"shares":42948300,"eps":-1.15437,"marketStatus":"Trading","change":0.18,"latestTime":"08-06 13:31:25 EDT","open":1.94,"high":2.21,"low":1.925,"amount":1072353.1925818,"amplitude":0.143939,"askPrice":2.17,"askSize":352,"bidPrice":2.16,"bidSize":649,"shortable":3,"etf":0,"ttmEps":-1.15437,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1786046400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1601524800000,"exchange":"NASDAQ","adjPreClose":1.98,"preHourTrading":{"tag":"盘前","latestPrice":1.95,"preClose":1.98,"latestTime":"07:29 EDT","volume":6415,"amount":12272.719969,"timestamp":1786015750318,"change":-0.03,"changeRate":-0.015152,"amplitude":0.035354},"postHourTrading":{"tag":"盘后","latestPrice":1.94,"preClose":1.98,"latestTime":"19:49 EDT","volume":12708,"amount":25299.1292,"timestamp":1785973761273,"change":-0.04,"changeRate":-0.020202,"amplitude":0.035354},"volumeRatio":0.395326,"impliedVol":0.5994,"impliedVolPercentile":0.2191},"requestUrl":"/m/hq/s/LUNG/tweets","defaultTab":"tweets","newsList":[{"id":"2656311429","title":"Pulmonx Corporation Earnings Call Signals Cautious Turn","url":"https://stock-news.laohu8.com/highlight/detail?id=2656311429","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656311429?lang=en_us&edition=fundamental","pubTime":"2026-08-02 08:18","pubTimestamp":1785629901,"startTime":"0","endTime":"0","summary":"Pulmonx Corporation (($LUNG)) has held its Q2 earnings call. Read on for the main highlights of the call. Pulmonx Corporation’s latest earnings cal...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulmonx-corporation-earnings-call-signals-cautious-turn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulmonx-corporation-earnings-call-signals-cautious-turn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LUNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656159413","title":"Earnings Release: Here's Why Analysts Cut Their Pulmonx Corporation (NASDAQ:LUNG) Price Target To US$3.40","url":"https://stock-news.laohu8.com/highlight/detail?id=2656159413","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656159413?lang=en_us&edition=fundamental","pubTime":"2026-08-01 22:41","pubTimestamp":1785595271,"startTime":"0","endTime":"0","summary":"Shareholders will be ecstatic, with their stake up 39% over the past week following Pulmonx Corporation 's...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lung/pulmonx/news/earnings-release-heres-why-analysts-cut-their-pulmonx-corpor","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lung/pulmonx/news/earnings-release-heres-why-analysts-cut-their-pulmonx-corpor","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":[".IXIC","LUNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655876745","title":"Piper Sandler Remains a Hold on Pulmonx (LUNG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2655876745","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655876745?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:58","pubTimestamp":1785409095,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Jason Bednar maintained a Hold rating on Pulmonx today and set a price target of $2.50. Bednar covers the Healthcare sector, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-hold-on-pulmonx-lung-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-hold-on-pulmonx-lung-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4588","XBI","LUNG","BK4585","BK4198","BK4082","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655866817","title":"Pulmonx Corp Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2655866817","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655866817?lang=en_us&edition=fundamental","pubTime":"2026-07-30 05:51","pubTimestamp":1785361900,"startTime":"0","endTime":"0","summary":"Pulmonx Corp reports results for the quarter ended June 30 - Earnings SummaryPulmonx CorpLUNG.OQreported a quarterly adjusted loss of 24 cents per share for the quarter ended June 30, higher than the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nL8N43V3LC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","LUNG","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655112138","title":"Pulmonx Publishes Investor Presentation on Zephyr Endobronchial Valves for Severe Emphysema Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2655112138","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655112138?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:47","pubTimestamp":1785358064,"startTime":"0","endTime":"0","summary":"Pulmonx publishes investor presentation on Zephyr endobronchial valves for severe emphysema treatmentPulmonx highlighted a USD 12 billion market opportunity for Zephyr endobronchial valves in severe e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL2lH85C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LUNG","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655542811","title":"Pulmonx Corp Q2 Revenue Falls, but Beats Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2655542811","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655542811?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:37","pubTimestamp":1785357436,"startTime":"0","endTime":"0","summary":"Pulmonx Corp Q2 revenue falls, but beats estimatesOverviewUS lung disease device maker's Q2 revenue fell 5% but beat analyst expectationsNet loss for Q2 narrowed 34% yr/yr as cost realignment reduced ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nL1N43V1DO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","LU1366192091.USD","LU0266013472.USD","LU2324357040.USD","SGXZ57979304.SGD","LU2265009873.SGD","LU2112291526.USD","LU0238689110.USD","LU1804176565.USD","LU2491050071.SGD","IE00BJT1NW94.SGD","LU2244417387.USD","IE0009355771.USD","LU0225283273.USD","LU0432979614.USD","LUNG","LU0114720955.EUR","LU2087625088.SGD","LU1989771016.USD","LU0122379950.USD","BSX","LU1983299246.USD","LU2506951958.HKD","LU1291159041.SGD","IE00B4R5TH58.HKD","LU0882574055.USD","LU0823417653.USD","LU0345769631.USD","LU0823416689.USD","LU2506952170.USD","LU2362541273.HKD","LU0823417737.USD","LU0077335932.USD","LU1720051017.SGD","LU0011850046.USD","LU1153585028.USD","LU2491049909.HKD","LU1989764748.USD","LU0048584097.USD","LU2242649171.HKD","BK4581","BK4585","GEHC","IE0002141913.USD","LU0950375773.USD","LU1989772923.USD","LU1989764664.SGD","IE00BFTCPJ56.SGD","SG9999001176.SGD","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655819503","title":"Pulmonx Q2 EPS USD -0.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2655819503","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655819503?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:19","pubTimestamp":1785356357,"startTime":"0","endTime":"0","summary":"Jul 29 (Reuters) - Pulmonx Q2 revenue USD 22.756 million vs. IBES estimate USD 22.4 million.:((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 29-JUL-202615:42:50 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nRSD6rGhFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4198","LUNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655816776","title":"Pulmonx Q2 FY26 Net Loss Narrows 34% to $10.1 Million; Revenue Drops 5% to $22.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655816776","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655816776?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:15","pubTimestamp":1785356147,"startTime":"0","endTime":"0","summary":"Pulmonx Q2 FY26 net loss narrows 34% to $10.1 million; revenue drops 5% to $22.8 millionPulmonx Q2 2026 revenue fell 5% from a year earlier to USD 22.8 million, with U.S. revenue down 4% to USD 14.2 m","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL75cXtp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","LU0314104364.USD","SG9999014039.USD","IE00B64PRP62.GBP","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD","IE00BKPKM429.USD","LUNG","BK4585","NDAQ","BK4082","BCDF","SG9999014013.SGD","SG9999014021.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4198","BK4588","IE00BN0W2T93.GBP","LU2210149790.SGD","BK4112","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655816338","title":"Pulmonx Q2 EPS $(0.24) Beats $(0.28) Estimate, Sales $22.756M Beat $22.400M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655816338","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655816338?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:06","pubTimestamp":1785355568,"startTime":"0","endTime":"0","summary":"Pulmonx Q2 EPS $(0.24) Beats $(0.28) Estimate, Sales $22.756M Beat $22.400M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/LUNG","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Pulmonx Q2 EPS $(0.24) Beats $(0.28) Estimate, Sales $22.756M Beat $22.400M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LUNG","BK4198","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655819169","title":"Pulmonx Outlook FY Gross Margin 76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655819169","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655819169?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:05","pubTimestamp":1785355503,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nPLX48KWQL:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","BK4082","LUNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655815088","title":"Pulmonx Q2 Pretax Profit USD -9.947 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655815088","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655815088?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:05","pubTimestamp":1785355503,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nPLX48KWQL:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LUNG","BK4082","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655053815","title":"Pulmonx Q2 Net Income USD -10.08 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655053815","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655053815?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:05","pubTimestamp":1785355503,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nPLX48KWQL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4198","LUNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655037815","title":"Pulmonx Q2 Revenue USD 22.756 Million VS. Ibes Estimate USD 22.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655037815","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655037815?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:05","pubTimestamp":1785355503,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nPLX48KWQL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","LUNG","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655811640","title":"Pulmonx Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2655811640","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655811640?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:05","pubTimestamp":1785355500,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., July  29, 2026  (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today repo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/29/3335551/0/en/Pulmonx-Reports-Second-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4129","BK4082","PMA","BK4198","LUNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655836860","title":"Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2655836860","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655836860?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:05","pubTimestamp":1785269100,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., July  28, 2026  (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/28/3334708/0/en/Pulmonx-to-Present-at-the-Canaccord-Genuity-46th-Annual-Growth-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","PMA","BK4129","LUNG","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654023704","title":"Pulmonx Corp Expected to Post a Loss of 28 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2654023704","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654023704?lang=en_us&edition=fundamental","pubTime":"2026-07-28 05:09","pubTimestamp":1785186561,"startTime":"0","endTime":"0","summary":"Pulmonx Corp <LUNG.OQ> expected to post a loss of28cents a share - Earnings PreviewPulmonx CorpLUNG.OQLUNG.Ois expected to  show a fall in quarterly revenue when it reports  results on July 29 for the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL8N43T24H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LUNG","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651549597","title":"Pulmonx to Report Q2 2026 Results, Host Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2651549597","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651549597?lang=en_us&edition=fundamental","pubTime":"2026-07-16 04:05","pubTimestamp":1784145927,"startTime":"0","endTime":"0","summary":"Pulmonx to report Q2 2026 results, host conference callPulmonx schedules Q2 2026 financial results release for July 29, 2026, following the market close.Management conference call set for July 29, 202","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL7cBv94:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BKPKM429.USD","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU2210150020.SGD","SG9999014013.SGD","LU0314104364.USD","BK4082","BK4112","IE00B64PRP62.GBP","BCDF","LU2095319765.USD","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","NDAQ","SG9999014005.SGD","LUNG","BK4198","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641970176","title":"Don't Ignore The Insider Selling In Pulmonx","url":"https://stock-news.laohu8.com/highlight/detail?id=2641970176","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641970176?lang=en_us&edition=fundamental","pubTime":"2026-06-07 21:10","pubTimestamp":1780837820,"startTime":"0","endTime":"0","summary":"Investors may wish to note that the CEO, President & Director of Pulmonx Corporation , Glendon French, recently netted...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice1-main-header/1585186795401"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lung/pulmonx/news/dont-ignore-the-insider-selling-in-pulmonx","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-lung/pulmonx/news/dont-ignore-the-insider-selling-in-pulmonx","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LUNG","BK4198","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641822160","title":"Pulmonx Shareholders Back Board, Auditor and Pay Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2641822160","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641822160?lang=en_us&edition=fundamental","pubTime":"2026-06-05 05:20","pubTimestamp":1780608044,"startTime":"0","endTime":"0","summary":"Pulmonx ( ($LUNG) ) has provided an update. On June 4, 2026, Pulmonx Corporation held its 2026 Annual Meeting of Stockholders, with approximately 7...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pulmonx-shareholders-back-board-auditor-and-pay-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pulmonx-shareholders-back-board-auditor-and-pay-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4198","LUNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641628011","title":"Pulmonx shareholders elect Class III directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2641628011","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641628011?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:05","pubTimestamp":1780603510,"startTime":"0","endTime":"0","summary":"Pulmonx held its annual shareholder meeting on June 4, 2026.Shareholders backed the slate of director nominees, seating three Class III directors to serve until the 2029 annual meeting.Appointment of BDO USA as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026 was ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulmonx Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDLbXp2H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BK4082","LUNG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://pulmonx.com","stockEarnings":[{"period":"1week","weight":0.584},{"period":"1month","weight":0.3378},{"period":"3month","weight":0.5591},{"period":"6month","weight":0.32},{"period":"1year","weight":0.2073},{"period":"ytd","weight":-0.1041}],"compareEarnings":[{"period":"1week","weight":0.0553},{"period":"1month","weight":0.0246},{"period":"3month","weight":0.0522},{"period":"6month","weight":0.1146},{"period":"1year","weight":0.2258},{"period":"ytd","weight":0.1289}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in Europe, the Middle East, Africa, the Asia-Pacific, the United States, and internationally. Pulmonx Corporation was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. The company was incorporated in 1995 and is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.124032},{"month":2,"riseRate":0.666667,"avgChangeRate":0.086482},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.108699},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.069835},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.060251},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.108365},{"month":7,"riseRate":0.666667,"avgChangeRate":0.029764},{"month":8,"riseRate":0.666667,"avgChangeRate":0.006994},{"month":9,"riseRate":0.2,"avgChangeRate":-0.026077},{"month":10,"riseRate":0.4,"avgChangeRate":-0.055336},{"month":11,"riseRate":0.5,"avgChangeRate":-0.058171},{"month":12,"riseRate":0.833333,"avgChangeRate":0.20888}],"exchange":"NASDAQ","name":"Pulmonx Corp","nameEN":"Pulmonx Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pulmonx Corp(LUNG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pulmonx Corp(LUNG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pulmonx Corp,LUNG,Pulmonx Corp股票,Pulmonx Corp股票老虎,Pulmonx Corp股票老虎国际,Pulmonx Corp行情,Pulmonx Corp股票行情,Pulmonx Corp股价,Pulmonx Corp股市,Pulmonx Corp股票价格,Pulmonx Corp股票交易,Pulmonx Corp股票购买,Pulmonx Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pulmonx Corp(LUNG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pulmonx Corp(LUNG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}